Indication
Pulmonary edema
Pulmonary edema is a pathological condition characterized by the abnormal accumulation of extravascular fluid within the interstitial tissue and alveolar spaces of the lungs. Read more about Pulmonary edema
0 drugs 0 manufacturers
Drugs that treat it
Common Pulmonary edema therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPulmonary edema is a pathological condition characterized by the abnormal accumulation of extravascular fluid within the interstitial tissue and alveolar spaces of the lungs.
Primarily affecting the respiratory system, this fluid shift impairs alveolar gas exchange and reduces pulmonary compliance.
Pathophysiologically, it arises either from elevated pulmonary microvascular hydrostatic pressure, typically secondary to left-sided heart failure or volume overload, or from increased alveolar-capillary membrane permeability due to direct or systemic inflammatory lung injury.
Patients classically present with acute or progressive dyspnea, orthopnea, tachypnea, rales, and hypoxemia, which can rapidly progress to life-threatening respiratory failure if left unaddressed.
- nih.gov
Pulmonary edema is a pathological condition characterized by the abnormal accumulation of extravascular fluid within the interstitial tissue and alveolar spaces of the lungs
- nih.gov
Pulmonary edema is a pathological condition characterized by the abnormal accumulation of extravascular fluid within the interstitial tissue and alveolar spaces of the lungs Patients classically present with acute or progressive dyspnea, orthopnea, tachypnea, rales, and hypoxemia, which can rapidly progress to life-threatening respiratory failure if left unaddressed
- nih.gov
Primarily affecting the respiratory system, this fluid shift impairs alveolar gas exchange and reduces pulmonary compliance Pathophysiologically, it arises either from elevated pulmonary microvascular hydrostatic pressure, typically secondary to left-sided heart failure or volume overload, or from increased alveolar-capillary membrane permeability due to direct or systemic inflammatory lung injury Patients classically present with acute or progressive dyspnea, orthopnea, tachypnea, rales, and hy...
- nih.gov
Primarily affecting the respiratory system, this fluid shift impairs alveolar gas exchange and reduces pulmonary compliance
- nih.gov
Pathophysiologically, it arises either from elevated pulmonary microvascular hydrostatic pressure, typically secondary to left-sided heart failure or volume overload, or from increased alveolar-capillary membrane permeability due to direct or systemic inflammatory lung injury
- nih.gov
Pathophysiologically, it arises either from elevated pulmonary microvascular hydrostatic pressure, typically secondary to left-sided heart failure or volume overload, or from increased alveolar-capillary membrane permeability due to direct or systemic inflammatory lung injury
Personalize your experience
Follow Pulmonary edema and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.